Lisata Therapeutics

Company snapshot

Lisata Therapeutics is a U.S. clinical-stage pharmaceutical company (Nasdaq: LSTA) dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.

• 15 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 US patent(s) indexed to this assignee profile.
• 15 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Lisata Therapeutics. Not investment advice.

• Peer + 0 momentum

  HALOZYME THERAPEUTICS

  TA overlap score 29

Recent activity

Latest pipeline, patent, and corporate events for Lisata Therapeutics.

1. Jun 8, 2026 Clinical update

   lymphokine-activated killer cells — Phase 2

2. Jun 8, 2026 Clinical update

   CLBS14 (low-dose) — Phase 2

3. Jun 8, 2026 Clinical update

   Auto-CD34+ cells — Phase 3

4. Jun 8, 2026 Clinical update

   CLBS119 — Phase 1

5. Jun 5, 2026 Clinical update

   therapeutic autologous dendritic cells — Phase 2

View all clinical trial activity →

• What is Lisata Therapeutics?

  Lisata Therapeutics is a pharma organization headquartered in basking ridge, USA. It trades on NYSE under ticker LSTA. Primary therapeutic focus areas include Covid-19, Chronic Myocardial Ischemia, Stage IV Melanoma, Kidney Cancer, Pancreatic Cancer. NovaPharmaNews links 15 clini

• Is Lisata Therapeutics publicly traded?

  Yes. Lisata Therapeutics is listed with ticker LSTA on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Lisata Therapeutics develop or market?

  We link 13 drug profile(s) where Lisata Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/lisata-therapeutics-inc#company-drugs.

• What are the latest developments for Lisata Therapeutics?

  In the last 12 months our linked public records show 15 trial program update(s) and 1 US patent grant(s) tied to this profile.

• What therapeutic areas does Lisata Therapeutics focus on?

  Lisata Therapeutics focuses on Covid-19, Chronic Myocardial Ischemia, Stage IV Melanoma based on our analysis of their pipeline programs and drug development activities.